Jeffrey D. Enslin - 29 Feb 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Mar 2024, 09:02:17 UTC
Prior SEC filing
01 Jun 2023
Next SEC filing
27 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey D. Enslin

Key filing fact

Jeffrey D. Enslin filed Form 4 for Glimpse Group, Inc. (VRAR) on 05 Mar 2024.

Key facts

  • This page summarizes Jeffrey D. Enslin's Form 4 filing for Glimpse Group, Inc. (VRAR).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Mar 2024, 09:02.

Change

  • Previous filing in this sequence was filed on 01 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRAR transaction

Common Stock

Award

Transaction value
$0
Shares
+215,631
Change %
+770%
Price
$0.000000
Shares after
243,631
Date
01 Mar 2024
Ownership
See Footnote
Footnotes
F2, F4
VRAR transaction

Common Stock

Award

Transaction value
$0
Shares
+25,000
Change %
+11%
Price
$0.000000
Shares after
243,631
Date
01 Mar 2024
Ownership
See Footnote
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRAR transaction Derivative

Stock Option (Right to Purchase)

Disposed to Issuer

Transaction value
$0
Shares
-359,385
Change %
-100%
Price
$0.000000*
Shares after
0
Date
29 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
359,385
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the forfeiture of fully vested options to purchase an aggregate of 359,385 shares of the issuer's common stock, consisting of options to purchase (i) 19,833 shares of common stock granted on June 22, 2018 with an exercise price of $3.25/share, (ii) 5,210 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (iii) 25,008 shares of common stock granted on October 15, 2018 with an exercise price of $4.00/share, (iv) 225,000 shares of common stock granted on March 8, 2019 with an exercise price of $4.00/share, (v) 30,218 shares of common stock granted on October 15, 2019 with an exercise price of $4.00/share, (vi) 22,224 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (vii) 11,892 shares of common stock granted on January 1, 2022 with an exercise price of $10.20/share, and (viii) 20,000 shares of common stock granted on February 27, 2023 with an exercise price of $5.00/share.

Footnote F2

Represents 215,631 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024.

Footnote F3

Represents 25,000 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024, as director compensation for calendar year 2024.

Footnote F4

The 243,631 shares shown as beneficially owned does not include 102,149 shares of common stock indirectly held by Mr. Enslin, through Perimetre Capital, LLC, an entity owned and managed by Mr. Enslin. Of the 243,631 shares of common stock shown as beneficially owned following the reported transactions, Mr. Enslin directly owns 3,000 shares. The remaining 240,631 shares are indirectly held by Mr. Ensin through Perimetre Capital, LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .